Reversing Prime recoupments. Reinstating BCBS-network pharmacies.
Request a Free Case ReviewPrime Therapeutics runs the audit program for 19 Blue Cross and Blue Shield plans plus the Magellan Rx specialty arm. A single flagged claim can trigger six- and seven-figure recoupments, termination for cause, and downstream loss of BCBS commercial, BCBS Medicare Part D, and Magellan Rx specialty network access. We defend pharmacies nationwide before the audit closes. Every day of delay changes your settlement posture.
.png)
Anthony's background as a former federal prosecutor and executive for major healthcare companies provided a level of expertise and insight that made all the difference. His deep understanding of healthcare law, particularly in litigation and compliance matters, helped navigate complex legal issues with ease.
With upmost professional respect, I will be forever grateful to have such caring individuals as Attorney Anthony Mahajan and Attorney Diana Yastrovskaya who come into my life, even though I am a business owner but I always felt I was treated as a friend and was made reaching out to them with ease.
I had a great experience working with Health Law Alliance. From the very beginning, their team was incredibly helpful, responsive, and professional. They answered all of my questions quickly and kept me informed throughout the entire process.
Anthony and his staff have gone above and beyond. His proactive communication and ability to handle complex legal scenarios effectively have been a significant asset. Highly recommended attorney.
Top-notch attorneys with an unparalleled scope of experience and breadth of knowledge. You will want them in your corner.
Had nothing but great experience from them. Knowledgeable and professional in all aspects. They have a vast knowledge in health care cases, great to be on your side against insurances.
Trustworthy and experienced.
By the time the Prime Therapeutics notice arrives, the downstream exposure is already stacked. Here is what your pharmacy is actually defending against.
Prime Therapeutics audit findings routinely demand recoupments of $250K to $4M+ per matter, with the audit team aggressively extrapolating a sampled-claim error rate across 12 to 24 months of total dispensing. Defense requires challenging both the sampled findings and the extrapolation methodology.
A Prime termination for cause designation flows downstream across the entire BCBS / Prime enterprise: Blue Cross Blue Shield commercial plans, BCBS Medicare Part D, and the Magellan Rx specialty network operated by the parent. Credentialing impact across multiple payors typically lands within 30 days of the termination notice.
Prime Therapeutics audit findings on controlled substances, compounding, and high-cost specialty claims are routinely referred to DEA, DOJ, HHS-OIG, and state boards of pharmacy. A PBM finding can become a civil investigative demand, a state board complaint, or a federal healthcare fraud investigation within weeks.
Four factors make Prime Therapeutics recoupments uniquely dangerous, and uniquely defensible if you know where Prime Therapeutics is actually vulnerable.
A PBM audit runs on the deadlines in your network agreement. What you produce, and when, becomes the record the PBM uses to set findings, chargebacks, and any network action.
Our bench includes a former Assistant U.S. Attorney (DOJ Director's Award nominee) and senior PBM operational counsel. We have run more than 2,000 audits across the major PBMs, including Prime Therapeutics. This is how we dismantle a Prime audit.
Within 24 hours: parse every deadline in the Prime audit notice, place a litigation hold on the claims at issue, and preserve adjudication logs and signature records before Prime's evidentiary window narrows.
Claim-by-claim reconstruction: prescriber PA rationale, plan criteria at time of fill, DAW code support, signature log validation, and controlled substance recordkeeping. Every flagged claim gets its own defense memo tied to the Prime audit citation.
We draft and file the written Prime appeal, quantify the extrapolation errors, and negotiate directly with the Prime audit team and provider relations on behalf of the pharmacy.
If Prime Therapeutics refuses a reasonable resolution, we file in federal court and pair the suit with regulatory defense at DEA, HHS-OIG, and the state board so a PBM dispute does not escalate into a license action or a criminal referral.
Health Law Alliance handles the response and any parallel appeal, licensing matter or referral as one coordinated matter, so the strategy does not change hands as the matter moves between forums.
The bench includes a former Assistant U.S. Attorney nominated for the DOJ Director's Award, senior healthcare-company counsel, and attorney-providers with experience across healthcare audits and investigations.
Agency and company marks identify former professional experience of individual HLA team members. They do not imply affiliation, endorsement, or a client relationship.
If any of these describe your 2024 to 2026 Prime Therapeutics-billed dispensing activity, you are already in the Prime audit pool whether or not the notice has arrived.
Outcomes are summarized for confidentiality. Client names, precise geography, and identifying facts are redacted.
Network Reinstated
A compounding pharmacy received a Prime termination for cause tied to compounded GLP-1 dispensing during the FDA shortage period. HLA's appeal brief documented compliance with the 503A pathway in effect on the dispense dates, addressed the OON appeal procedural record, and obtained full reinstatement across Prime, BCBS commercial plans, and Magellan Rx without a recoupment.
Recoupment Reversed
A multi-location independent pharmacy faced a Prime specialty audit citing DAW code mismatches and signature log gaps across 18 months of dispenses. HLA reconstructed the underlying claims, challenged the extrapolation methodology, and negotiated a final settlement substantially below the original recoupment demand.
State Board Closed
A Prime on-site audit produced a state board of pharmacy referral alleging recordkeeping and dispensing violations. HLA's regulatory response addressed each cited deficiency and documented compliance with the state pharmacy practice act on the dispense dates; the board closed the matter with no discipline.
Attorney advertising. Prior results do not guarantee a similar outcome. Case summaries are generalized for confidentiality and are not a substitute for legal advice on your specific audit.
Eight questions that come up on almost every first call.
Before you write a single page of your Prime Therapeutics response, have a privileged conversation with attorneys who have overseen 2,000+ audits across the major PBMs, including reversed Prime terminations and reduced Prime Therapeutics recoupments. Free, confidential, no retainer.